Free Trial
NASDAQ:IMAC

IMAC (IMAC) Stock Price, News & Analysis

IMAC logo
$0.70 +0.01 (+0.78%)
As of 02/20/2025

About IMAC Stock (NASDAQ:IMAC)

Key Stats

Today's Range
$0.66
$0.70
50-Day Range
$0.54
$1.41
52-Week Range
$0.75
$1.65
Volume
120,273 shs
Average Volume
708,132 shs
Market Capitalization
$18.51 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

IMAC Holdings, Inc. owns, manages, and subleases a chain of innovative medical advancements and care regeneration centers in the United States. The company's outpatient medical clinics provide regenerative, orthopedic, and minimally invasive procedures and therapies to patients with sports injuries, ligament and tendon damage, and other related soft tissue conditions, as well as back, knee, and joint pains. It also provides physical therapy and spinal decompression, and chiropractic manipulation. The company owns or manages 15 outpatient medical clinics in Kentucky, Missouri, Tennessee, Illinois, Louisiana, and Florida. IMAC Holdings, Inc. was founded in 2000 and is headquartered in Brentwood, Tennessee.

Receive IMAC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IMAC and its competitors with MarketBeat's FREE daily newsletter.

IMAC Stock News Headlines

Ignite Proteomics complete acquisition of PLA code 0249U
Ex-CIA Advisor: Trump 2.0 Could “Send Gold to $10,000”
Experts forecast gold's price racing to $4,000… and an ex-CIA advisor predicts we'll see gold hit $10,000. Should you sit on the sideline while this is happening?
A larger iMac might not be dead, after all
See More Headlines

IMAC Stock Analysis - Frequently Asked Questions

IMAC's stock was trading at $1.27 at the start of the year. Since then, IMAC shares have decreased by 45.0% and is now trading at $0.6990.
View the best growth stocks for 2025 here
.

IMAC Holdings, Inc. (NASDAQ:IMAC) posted its earnings results on Thursday, April, 14th. The company reported ($0.11) EPS for the quarter, missing the consensus estimate of ($0.09) by $0.03. IMAC had a negative trailing twelve-month return on equity of 52.17% and a negative net margin of 75.40%.

IMAC (IMAC) raised $4 million in an IPO on the week of February 11th 2019. The company issued 900,000 shares at a price of $5.00 per share. Dawson James Securities and Cuttone acted as the underwriters for the IPO.

Shares of IMAC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that IMAC investors own include Advanced Micro Devices (AMD), Nokia Oyj (NOK), iBio (IBIO), VBI Vaccines (VBIV), Avino Silver & Gold Mines (ASM), Avino Silver & Gold Mines (ASM) and Energy Transfer (ET).

Company Calendar

Last Earnings
4/14/2022
Today
2/21/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Specialty Outpatient Clinics
Sub-Industry
N/A
Current Symbol
NASDAQ:IMAC
Fax
N/A
Employees
106
Year Founded
N/A

Profitability

Net Income
$-10,540,000.00
Pretax Margin
-75.40%

Debt

Sales & Book Value

Annual Sales
$15.22 million
Book Value
$0.69 per share

Miscellaneous

Free Float
23,837,000
Market Cap
$18.51 million
Optionable
Not Optionable
Beta
-0.88
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for March 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:IMAC) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners